#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypochromic anaemia Castleman's disease Acute on chronic liver failure Homocystinuria Paraneoplastic neurological syndrome MELAS syndrome Testicular leiomyosarcoma Glioblastoma multiforme Bulbospinal muscular atrophy congenital Dermatitis Cardiac amyloidosis Hyperinsulinism Non-small cell lung cancer Pericarditis Hepatic cirrhosis More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Treatment Uterine leiomyosarcoma – Treatment Idiopathic pulmonary fibrosis – Diagnostics Paroxysmal nocturnal haemoglobinuria – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Glycogen storage disease type II – Trials in Disease Alagille syndrome – Life with Disease Angelman’s syndrome – Trials in Disease Mantle cell lymphoma stage II – Life with Disease Mucous membrane pemphigoid – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CC-97540 Midomafetamine Hydrochloride Anhydrous Cyclophosphamide Octocog Alfa Cangrelor Tetrasodium Carbidopa Sym023 Thiamine Crovalimab 177LU-PSMA-I&T Proline N-Acetylhistidine USNOFLAST FERUMOXTRAN-10 Ceftazidime BRENSOCATIB Cisplatin Tecaginlimab Mosaic Hbcoreag Co-Trimoxazole More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Ebola disease Anal cancer metastatic Cervical dysplasia Anxiety disorder Systemic scleroderma Langerhans' cell histiocytosis Perineal injury Alveolar bone defect Pulmonary resection Malignant melanoma of eyelid Rectal cancer Small fibre neuropathy Adrenogenital syndrome Hypogonadism male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Berotralstat
    Czechia France Germany Italy Poland Slovakia +1

  • Study on the Safety and Effectiveness of OC-1 Therapy for Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
    Spain

  • Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Iph5201
    • Carboplatin
    • Cisplatin
    France Greece Hungary Poland

  • Study of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Sarilumab
    Bulgaria Finland France Germany Greece Hungary +5

  • Study of GNT0003 and imlifidase in adults with Crigler-Najjar syndrome who require daily phototherapy and have pre-existing AAV8 antibodies

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crigler-Najjar syndrome
    Investigated Drugs:
    • Imlifidase
    • Adeno-Associated Viral Vector Serotype 2/8 Containing The Human Ugt1A1 Gene
    • Amoxicillin Sodium
    France

  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenosquamous cell lung cancer
    • Bladder cancer
    Investigated Drugs:
    • Jk06
    Belgium Spain
Previous Page
1 … 313 314 315 316 317 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!